A recent abstract from the American Society of Hematology has demonstrated the importance of FerriScan in the management of patients with hemoglobinopathies.
The abstract "Central Role of LIC-R2 (Ferriscan) Determination in Patients with Hemoglobinopathies: Licnet Experience" states
"These findings show that LIC-R2 (Ferriscan®) is crucial to have accurate and reliable measures for iron body burden control in hemoglobinopathies."
Please click here to view the full abstract.